anti-PDGFR-beta mAbs (Imclone)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-PDGFR-beta mAbs (Imclone)
Drug Alias Nameanti-PDGF receptor-beta mAbs (Imclone)1B3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionPlatelet-derived growth factor receptor beta inhibitors
TargetsPlatelet-derived growth factor receptor beta
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImclone Systems
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImclone Systems
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A